FOR IMMEDIATE RELEASE 2013-38 Washington, D.C., March

New Post Public Reply Private Reply Replies (0) Message Board
MaxShockeR
FOR IMMEDIATE RELEASE 2013-38 Washington, D.C., March 11, 2013 — The Securities and Exchange Commission today charged two investment advisers at Oppenheimer & Co. with misleading investors about the valuation policies and performance of a private equity fund they manage. Additional Materials SEC Order An SEC investigation found that Oppenheimer Asset Management and Oppenheimer Alternative Investment Management disseminated misleading quarterly reports and marketing materials stating that the fund’s holdings of other private equity funds were valued “based on the underlying managers’ estimated values.” However, the portfolio manager of the Oppenheimer fund actually valued the fund’s largest investment at a significant markup to the underlying manager’s estimated value, a change that made the fund’s performance appear significantly better as measured by its internal rate of return. Oppenheimer agreed to pay more than $2.8 million to settle the SEC’s charges. The Massachusetts Attorney General’s office today announced a related action and additional financial penalty against Oppenheimer. “Honest disclosure about how investments are valued and how performance is measured is vital to private equity investors,” said George S. Canellos, Acting Director of the SEC’s Division of Enforcement. “This action against Oppenheimer for misleadingly writing up the value of illiquid investments is clear warning that the SEC will not tolerate lax disclosure practices in the marketing of private equity funds.” According to the SEC’s order instituting settled administrative proceedings, the Oppenheimer advisers marketed Oppenheimer Global Resource Private Equity Fund I L.P. (OGR) to investors from around October 2009 to June 2010. OGR is a fund that invests in other private equity funds, and it was marketed primarily to pensions, foundations, and endowments as well as high net worth individuals and families. According to the SEC’s order, OGR’s largest investment — Cartesian Investors-A LLC — was not valued based on the underlying managers’ estimated values. OGR’s portfolio manager himself valued Cartesian at a significant markup to the underlying manager’s estimated value. OAM’s change in valuation methodology resulted in a material increase in OGR’s performance as measured by its internal rate of return, which is a metric commonly used to compare the profitability of various investments. For the quarter ended June 30, 2009, the portfolio manager’s markup of OGR’s Cartesian investment increased the internal rate of return from approximately 3.8 to 38.3 percent. “Particularly in the current difficult fundraising environment that can incentivize private equity managers to artificially inflate portfolio valuations, firms must implement policies and procedures to ensure that investors receive performance data derived from the disclosed valuation methodology,” said Julie M. Riewe, Deputy Chief of the SEC Enforcement Division’s Asset Management Unit. “Oppenheimer failed to implement such procedures and provided investors with misleading information about its valuation policies and performance numbers.” The SEC’s order found that former OAM employees made the following misrepresentations to potential investors: The increase in Cartesian’s value was due to an increase in Cartesian’s performance when, in fact, the increase was attributable to the portfolio manager’s new valuation method.  A third-party valuation firm used by Cartesian’s underlying manager wrote up the value of Cartesian, which was untrue.  OGR’s underlying funds were audited by independent third-party auditors when, in fact, Cartesian was unaudited. The SEC’s order also found that Oppenheimer Asset Management’s written policies and procedures were not reasonably designed to ensure that valuations provided to prospective and existing investors were presented in a manner consistent with written representations to investors and prospective investors. Oppenheimer Asset Management’s conduct violated Sections 17(a)(2) and 17(a)(3) of the Securities Act of 1933 and Section 206(4) of the Investment Advisers Act of 1940 and Rules 206(4)-7 and 206(4)-8. Without admitting or denying the findings, Oppenheimer agreed to pay a $617,579 penalty and return $2,269,098 to those who invested in OGR during the time period when the misrepresentations were made. Oppenheimer consented to a censure and agreed to cease and desist from committing or causing any future violations of the securities laws. The firm is required to retain an independent consultant to conduct a review of its valuation policies and procedures. Oppenheimer will pay an additional penalty of $132,421 to the Commonwealth of Massachusetts in the related action taken by the Massachusetts Attorney General. The SEC’s investigation, which is continuing, was conducted by Panayiota K. Bougiamas and Igor Rozenblit of the Asset Management Unit and Lisa Knoop. It was supervised by Valerie A. Szczepanik. The SEC acknowledges the assistance of the Massachusetts Attorney General’s office. # # #

View More
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FDA Greenlights VELO: A Turning Point for Reynolds?

Updated Category News Views 33

FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...

Continue Reading
Tampa General Elevates Lokenauth to CFO Amid Growth

Updated Category News Views 36

Charting New Waters at Tampa General Out here in the blue, the tides of healthcare can swell mighty quick. That's where Tampa General Hospital keeps its anchor firm, announcing Lijah Lokenauth's leap to Executive VP and CFO. If you ask me, it's all about keeping the ship steady—this fella's been steering their financial boat through some hefty waves since 2018....

Continue Reading
Anguilla Culinary Festival 2027: A Feast Beyond Food

Updated Category News Views 101

A Culinary Quest in the Caribbean Imagine this: a culinary pilgrimage where the Caribbean’s essence is served on a plate. The Anguilla Culinary Experience (ACE), set for April 28 through May 2, 2027, isn't just about stretching waistbands. It’s about embracing the spirit and flavors of Anguilla, one of the world's cherished culinary hotspots. Cooking with Purpose ACE...

Continue Reading
Cboe's Third Quarter Packs a Punch with Strong Gains

Updated Category News Views 62

Making Waves in the Market There's no sugar-coating it—Cboe Global Markets has had a hell of a third quarter in 2026. With their diluted EPS climbing to a record $4.08, a 43% jump from last year, it's no surprise their stock ticker, CBOE, is catching some eyes. Adjusted diluted EPS also made a splash, soaring 36% to $3.63 compared to 2025 figures. Their strategic moves...

Continue Reading
Sunset World Group: 32 Years of Beachside Legacy

Updated Category News Views 18

Celebrating a Beachside Milestone Out there in the sun-soaked corners of Cancun, it's another sunburnt milestone for the folks over at Sunset Royal Beach Resort. We're talking a full 32 years of greeting guests with their signature tropical flair. Now that's the kind of longevity you just don't find in today's fleeting hospitality market. A pat on the back to any...

Continue Reading
Runners Hit NYC Streets to Spotlight Liver Disease

Updated Category News Views 9

From the Heart: Marathon Runners Champion Liver Disease Awareness There’s something raw and powerful about a community uniting to raise awareness for a cause that's touched so many lives. This Sunday, the TCS New York City Marathon becomes more than a race—it transforms into a moving tapestry of human stories, as runners take to the streets to spotlight liver disease...

Continue Reading
Buyers Edge Appoints Sam Peterson as CTO to Lead AI Shift

Updated Category News Views 68

Anticipating a New Era of AI with Buyers Edge The rumble through the procurement world was more of a jolt this week as Buyers Edge Platform (BEP) threw a new player into the tech gauntlet. Sam Peterson has been handed the reins as the Chief Technology Officer. The goal? To supercharge BEP's innovation engine with some AI-driven gusto. What's in the Cards for Buyers Edge...

Continue Reading
MediaGo Wins Big in France with Optimized Strategies

Updated Category News Views 55

MediaGo's Winning Edge in Advertising Shake the dust off your boots and get ready for a tale of triumph straight out of San Francisco. MediaGo, the top dog in global intelligent advertising platforms, just added a couple of shiny awards to its trophy case thanks to the prestigious Les Cas d'OR 2026 in France. And let me tell ya, these wins aren't just about some pretty...

Continue Reading
Huawei's New O&M Strategies: A Game-Changer?

Updated Category News Views 42

Huawei's Latest O&M Revolution: What's on the Table? With Huawei dropping fresh O&M solutions at HUAWEI CONNECT 2026 in Shanghai, they're not just shaking things up—they're kicking the whole operation management game into hyperdrive using AI. They're zeroing in on the whole digital twin strategy, boasting some nifty pre-event, in-process, and post-event capabilities to...

Continue Reading
Standards Touch 2027 Student Paper Competition

Updated Category News Views 37

Diving into Trust: ANSI's 2027 Paper Challenge Out from the buzz of New York, the American National Standards Institute (ANSI) has stirred up some real brain-teasing talk for students across the country. Kicking off the 2027 Student Paper Competition, they're handing students a chance to ponder a question we take for granted every day. Do we ever truly consider what makes...

Continue Reading

Top 5 Most Recently Viewed Articles

H.C. Wainwright Adjusts Target for Inventiva Amid Changes

Updated Category News Views 78

Understanding H.C. Wainwright's Updated Price Target for Inventiva Recently, H.C. Wainwright made notable adjustments to its price target for Inventiva SA (NASDAQ: IVA), lowering it to $13.00 from the previous $14.00 while continuing to maintain a Buy rating. This decision came closely after Inventiva announced an important financing deal, which is crucial for the...

Continue Reading
Zymeworks Unveils Innovative Cancer Therapies at AACR Meeting

Updated Category News Views 226

Breakthrough Cancer Therapies: Zymeworks Announcements Zymeworks Inc., a leading name in biotechnology, is making headlines with the introduction of cutting-edge treatments aimed at tackling some of the most formidable health challenges. With a commitment to enhancing therapeutic options for cancer and other diseases, Zymeworks is developing multifunctional...

Continue Reading
Ontrak Health and Sentara Team Up for Enhanced Care Solutions

Updated Category News Views 30

Ontrak Health Expands Behavioral Health Collaboration Ontrak, Inc. (NASDAQ: OTRK), an innovative leader in AI-powered behavioral healthcare, is excited to share details of its expanded partnership with Sentara Health Plans. This significant move is set to enhance services in the behavioral health domain, promising improved outcomes for a wide range of members. Expanding...

Continue Reading
Gigasoft's ProEssentials v10 Targets AI Need for Accurate Coding

Updated Category News Views 340

AI Code Hallucinations: A Real Developer Nightmare Cracking the code is one thing, but developers sure aren’t laughing when they have to deal with hallucinations from their AI tools. You know the drill: you ask your shiny AI assistant for charting code and, voila, you're confronted with property names that don’t exist. Cue the frustration, the documentation digging,...

Continue Reading
Exploring Middlefield Canadian Income PCC's Asset Value Insights

Updated Category News Views 88

Understanding Middlefield Canadian Income PCC's Net Asset Value Middlefield Canadian Income PCC is a protected cell company that plays a significant role in asset management. It's important for investors to keep an eye on the company's financial metrics, particularly the Net Asset Value (NAV), as it serves as a key indicator of the company's financial health and...

Continue Reading